Mounjaro Price Update: A Better Outcome for UK Patients

By Dr Mark Larkin, PhD, Director, Pharmacy Price Hound

Recent reports of a significant Mounjaro (tirzepatide) price increase have been concerning. However, my analysis of the market indicates the situation is better than first expected for UK consumers.

The Key Insight for You

While the official list price is rising, manufacturer Eli Lilly announced today substantial discounts to UK suppliers. This means the actual cost to pharmacies will be lower, and the price you pay for your prescription, while still increasing, will be less severe than initially projected.

What This Means for Your Wallet

You will see an increase in your prescription price, but it should be more manageable. This reinforces the critical need to compare prices. The cost may still vary significantly between pharmacies. Use our tools to ensure you are not overpaying.

Why This Happened

This is a strategic move by Lilly, likely in response to the competitive UK market and the need to demonstrate value for future NHS consideration. For you, the consumer, it’s a less negative outcome that reduced the financial impact.

Your Action Plan

Continue to monitor the market. Price fluctuations are common. The most effective way to control your cost remains the same:  always shop around before you fill your prescription.